280 likes | 540 Views
Fourth External Review and JCB 29. TDR to change, evolve and grow. Need for new TDR vision/strategy triggered by critical trends in global research environment. DEC's left behind in priority setting. Growing regional variation. Enhanced research capabilities in DEC's. Global research environment for tropical diseases.
E N D
1. Robert Ridley
3. Need for new TDR vision/strategy triggered by critical trends in global research environment
4. What is Needed?
5. Implications for TDR
6. Modelling the system to address TDR's role
7. Responding to needs
8. Implications
9. What we want to achieve
11. Stewardship Vision
To help focus global efforts on priority needs in infectious diseases research in disease endemic countries
Overall objective
To facilitate and foster knowledge management, needs assessment, priority setting and progress analysis for health research on infectious diseases of poverty, and to provide a neutral platform for stakeholders to discuss and harmonize their activities with disease endemic countries playing a pivotal role in the agenda setting.
12. Research capacity
13. Individual
14. Mainstream Capacity Building
15. Empowerment Vision
DEC Leadership in health research, training and partnerships within sound scientific, ethical and quality frameworks
Overall objective
To develop excellence and leadership in health research and decision making so that high quality institutional and national systems can identify and manage research priorities.
16. Research Business Lines and Gaps
17. Planned activities across research continuum
18. Business Lines Greater clarity of activity
Easier to justify funding
Easier to define interactions
External partners
Internal within WHO
Closer cooperation and easier collaboration with WHO control departments and regional offices
Form follows function leading to:
Transparency of portfolio
Easier review and evaluation
19. Business Lines can enter / exit / change over time
20. Determinants of BL entry / exit Entry / exit criteria based on comparative added value, needs and cost
STAC to validate entry / exit
Comparative added value and new opportunities informed by:
stewardship analysis and consultation on priority needs
empowerment and capacity needs
innovation fund driven opportunities
21. Innovation Fund Fund @ $1M per year
Open to applications on any topic relevant to TDR's research, empowerment and stewardship mission
No limit to request, may be for limited funding at project level (rapid response) or larger funding for major initiative (detailed negotiation)
Goal to initiate and stimulate sustainable activity that will have impact
Interface with stewardship for topics to be addressed
Possible incubation of future business lines
22. Issues associated with management of BL's Entry / exit
DEC's play pivotal role
Synergies across functions and business lines
Mainstreaming cross-cutting issues e.g. gender
Overall balance
e.g. disease scope expansion conservative and meets JCB mandate
Stewardship has broad scope
BL 6 (helminths)
BL 11 (integrated CDI)
23. Delivering Impact – making a difference
25. Dashboards linking BL performance to strategic indicators
26. Committees central to strategy development plus monitoring and evaluation
27. Portfolio review links STAC, SAC's and secretariat
28. Timing of reviews to ensure strategic impact
29. Role of governance
30. Regional emphasis and leverage TDR Governance systems reinforced
Links to co-sponsor regional offices and ACHR's
Stewardship and empowerment activities will link to regional partners
Concept of regional associations of tropical diseases and co-hosted meetings (stewardship)
Concept of 'satellite' business lines (empowerment)
Research BL's strongly link to regions
VL elimination
Diagnostics specimen bank management and operation
General emphasis on DEC led management of projects
32. Operational Processes
33. TDR proposed structure
37. Justification for increase Stewardship role is new and requires new resources
Empowerment BL to grow by 30% over 6 years and is further manifest within research activity
Proposed objectives and deliverables meet needs of a balanced portfolio.
Inability to reach budget targets clearly associated with corresponding lack of end products
Research now better served globally, but more complex with more (focused) issues needing to be professionally covered
38. 2008-2009 budgets Budget 1 (aligned to business plan)
$120 M
Budget 2 (back-up)
$ 98 M
1 business line not initiated
several business lines with reduced number of objectives
Slower scale up of stewardship role
39. Resource mobilisation targets
40. What's New? Addresses MDG's and health research interface with development
Stewardship goals – fostering
Capacity strengthening to empowerment goals
Focus on leadership
Research goals more strategically focused
Re-emphasise committees and networks
Regional focus / devolved activities
Better cohesion and coherence with external partners, and WHO
Link to control departments
Link to regions
Link to primary health care (IR community emphasis)
Link to innovation (IGWG)
Professionalised processes incl. STAC portfolio review
41. Comparison between 2006/7 and 2008/9 budget
42. Some final thoughts On the right track, but not there yet
Responsiveness to country needs – who sets the agenda?
Stewardship and empowerment will take time
Looking to cultural shifts in emphasis
Fostering, outreach, facilitation, networks
Mainstreaming capacity building for empowerment
Focused professionalism of operation with transparency and openness to review
Recognising and building on unique nature of the 'Special Programme'
43. Assistance for Discussion Top level endorsement of vision and strategy
Guidance sought on whether previous concerns adequately addressed
Objectives and outputs of Stewardship function incl. outreach
Objectives and outputs of Empowerment function incl. partnerships / networks
Objectives and outputs of Research on Neglected Priorities function
Business lines: focus, entry / exit and management
Cross-cutting issues: e.g. gender
Mechanisms for DEC's to play a pivotal role
Regionalisation / decentralisation and interfaces with co-sponsoring agencies
Priority setting criteria and processes e.g. through committees
Monitoring and evaluation
Prospective 5th external review
Implementation plan incl. human resources
Role of STAC
Approve budget with / without amendment
Agree TDR to follow WHO practice on reporting by activity and personnel
Agree to 10% flexibility in budget allocation